TAK-003 is currently undergoing regulatory review for potential licensure in both the European Union
Marinus has broadened inclusion criteria in the RAISE trial to allow for enrollment of patients previously treated with IV anesthesia.
Dupixent is the first and only biologic medicine approved to treat moderate-to-severe atopic dermatitis from infancy to adulthood
We have grown from $10 billion to $80 billion. India is not too far from reaching the league of top-10 countries in Biotech's global ecosystem”
Based on a post hoc analysis, fewer required respiratory interventions
The Innopack confex is a perfect platform for exhibitors to demonstrate their latest developments in the fields of pharmaceutical packaging, labelling, drug delivery device design and engineering.
To address the preventive & primary healthcare delivery gaps in India
RH Capital, a leading women's health venture capital fund, announced three new investments to improve health outcomes for women in the US.
Norliqva was approved by the FDA on February 24, 2022 and is now available through normal retail distribution.
Focussed campaigns for old age homes, schools/colleges, prisons, brick kilns to be taken up by States/UTs
Subscribe To Our Newsletter & Stay Updated
